Qiagen
Europe, Limburg, The Netherlands, Venlo
Description
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions.
Investor Profile
Qiagen has made 10 investments, with 0 in the past 12 months and 40% as lead.
Stage Focus
- Series B (30%)
- Series A (30%)
- Seed (20%)
- Series Unknown (10%)
- Grant (10%)
Country Focus
- United States (50%)
- Germany (40%)
- Canada (10%)
Industry Focus
- Biotechnology
- Health Diagnostics
- Health Care
- Genetics
- Life Science
- Medical Device
- Precision Medicine
- Biopharma
- Oncology
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
